BNR
Burning Rock Biotech Limited
NASDAQ · CNHealthcareMedical - Diagnostics & Research
$10.07+1.00%
Price as of Jul 20, 2026
BNR valuation
Burning Rock Biotech Limited valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.39x
- Price / sales
- 1.40x
- Price / cash flow
- -21.00x
Enterprise value
- Enterprise value
- $47.8M
- EV / sales
- 0.63x
- EV / EBITDA
- -14.01x
- EV / EBIT
- -5.53x
- Market cap
- $106.2M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.